185 results on '"Yoshida, Yoichiro"'
Search Results
2. Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG)
3. Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study)
4. Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study)
5. Intraoperative pressure monitoring of the lower leg for preventing compression-related complications associated with the lithotomy position
6. Detection of carbon dioxide embolism by transesophageal echocardiography during transanal/perineal endoscopic surgery: a pilot study
7. Safety and effectiveness of high ligation of the inferior mesenteric artery for cancer of the descending colon under indocyanine green fluorescence imaging: a pilot study
8. Acute chemotherapy-induced peripheral neuropathy due to oxaliplatin administration without cold stimulation
9. Avoiding urethral and rectal injury during transperineal abdominoperineal resection in male patients with anorectal cancer
10. Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancer
11. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death
12. 5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabine
13. The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy
14. Phase 2 study of perioperative chemotherapy with SOX and surgery for stage III colorectal cancer (SOS3 study)
15. Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)
16. Evaluation of vascular pain in patients with colorectal cancer receiving peripheral venous chemotherapy with or without oxaliplatin
17. Analysis of Circulating DNA to Assess Prognoses for Metastatic Colorectal Cancer Patients Treated with Regorafenib Dose-Escalation Therapy: A Retrospective, Exploratory Analysis of the RECC Trial.
18. Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
19. Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
20. Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients
21. Endoscopic mucosal incision for successful treatment of submucosal abscess extending the full length of the esophagus due to fish bone: report of a case
22. Demonstration of equivocal anti-glomerular basement membrane antibody positivity as a non-specific reaction through multiple immunologic assays in a case of pediatric asymptomatic hematuria
23. Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.
24. Implementation of geriatric assessment and long-term care insurance system by medical professionals in cancer treatment: a nationwide survey in Japan.
25. Binding of RNA to p53 regulates its oligomerization and DNA-binding activity
26. Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX
27. MO36-4 Asian subgroup analysis in global POLAR program of calmangafodipir on top of mFOLFOX6 for the prevention of CIPN
28. Low pH enhances Sp1 DNA binding activity and interaction with TBP
29. Pilot study of the early start of chemotherapy after resection of primary colorectal cancer with distant metastases (Pearl Star 01)
30. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs.
31. A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer.
32. Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study.
33. A case of carbon dioxide embolism during the transperineal approach in total pelvic exenteration for advanced anorectal cancer.
34. Contribution of long-chain fatty acid to induction of myeloid-derived suppressor cell (MDSC)-like cells – induction of MDSC by lipid vesicles (liposome).
35. A Marked Response to Immunosuppressive Intervention for Abruptly Occurring Cardiac Complications in a Case of Juvenile Systemic Sclerosis Overlapped with Dermatomyositis
36. Effects of the publication of Clinical Guidelines for the Management of Chemotherapy-Induced Peripheral Neuropathy on the Administration Preferences of Oncology Specialists: Japanese Association of Supportive Care in Cancer.
37. Tu1730 - Efficacy of Abdominal Fascia and Skin Closure Using Triclosan-Coated Sutures on Incidence of Superficial Incisional Surgical Site Infections after Gastroenterologic Surgery
38. Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo.
39. Difference in Neutropenia due to Administration Schedule of TAS-102.
40. Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration.
41. P2-7-6 - Administration of Chemotherapy Via Median Cubital Vein Without Central Venous Access Port for Colorectal Cancer
42. O3-2-4 - Evaluation of Phlebitis Attribute to Chemotherapy in Colorectal Cancer Patients of Our Institution
43. A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab.
44. Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer.
45. A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy.
46. Multiple Ectopic Hepatocellular Carcinomas Arising in the Abdominal Cavity.
47. Early Start of Chemotherapy after Resection of Brain Metastasis from Colon Cancer with Synchronous Multiple Liver Metastases.
48. Early Start of Chemotherapy after Resection of Primary Colon Cancer with Synchronous Multiple Liver Metastases:A Case Report.
49. ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA.
50. Human mitochondrial transcription factor A binds preferentially to oxidatively damaged DNA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.